Literature DB >> 9045880

Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.

N V Sipsas1, S A Kalams, A Trocha, S He, W A Blattner, B D Walker, R P Johnson.   

Abstract

Characterization of the cytotoxic T lymphocyte (CTL) response against HIV-1 has been limited by the use of target cells expressing viral proteins from laboratory isolates of HIV-1. This approach has favored identification of group-specific CTL responses and precluded assessment of the extent of type-specific CTL responses directed against HIV-1. Using cells expressing viral proteins from the HIV-1 IIIB strain, we performed a detailed characterization of HIV-1-specific CTL response in three laboratory workers accidentally infected with HIV-1 IIIB. Eight of the epitopes identified were group specific, lying in relatively conserved regions of Gag, reverse transcriptase, and envelope. Three type-specific epitopes were identified, two of them in highly variable regions of envelope. In longitudinal studies in one subject, seven different epitopes and five different restricting HLA class I alleles were identified, with a progressive increase in the number of CTL epitopes recognized by this subject over time. Our data demonstrate that type-specific CTL responses make up a significant proportion of the host cellular immune response against HIV-1 and that a broadening of epitope specificity may occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045880      PMCID: PMC507860          DOI: 10.1172/JCI119221

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.

Authors:  S H Pincus; K G Messer; P L Nara; W A Blattner; G Colclough; M Reitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

2.  Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.

Authors:  F di Marzo Veronese; M S Reitz; G Gupta; M Robert-Guroff; C Boyer-Thompson; A Louie; R C Gallo; P Lusso
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

3.  Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles.

Authors:  M Bunce; K I Welsh
Journal:  Tissue Antigens       Date:  1994-01

4.  Definition of specific peptide motifs for four major HLA-A alleles.

Authors:  R T Kubo; A Sette; H M Grey; E Appella; K Sakaguchi; N Z Zhu; D Arnott; N Sherman; J Shabanowitz; H Michel
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

5.  Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.

Authors:  S H Pincus; K G Messer; D H Schwartz; G K Lewis; B S Graham; W A Blattner; G Fisher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.

Authors:  J Sutton; S Rowland-Jones; W Rosenberg; D Nixon; F Gotch; X M Gao; N Murray; A Spoonas; P Driscoll; M Smith
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

8.  Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.

Authors:  R P Johnson; S A Hammond; A Trocha; R F Siliciano; B D Walker
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Authors:  S A Kalams; R P Johnson; A K Trocha; M J Dynan; H S Ngo; R T D'Aquila; J T Kurnick; B D Walker
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.

Authors:  R P Johnson; A Trocha; T M Buchanan; B D Walker
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  19 in total

1.  Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.

Authors:  A Samri; G Haas; J Duntze; J M Bouley; V Calvez; C Katlama; B Autran
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R L Glickman; J Q Yang; A Kaur; J T Dion; M J Mulligan; R C Desrosiers
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.

Authors:  D Durali; J Morvan; F Letourneur; D Schmitt; N Guegan; M Dalod; S Saragosti; D Sicard; J P Levy; E Gomard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.

Authors:  C L Day; A K Shea; M A Altfeld; D P Olson; S P Buchbinder; F M Hecht; E S Rosenberg; B D Walker; S A Kalams
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.

Authors:  Xu G Yu; Marylyn M Addo; Eric S Rosenberg; William R Rodriguez; Paul K Lee; Cecily A Fitzpatrick; Mary N Johnston; Daryld Strick; Philip J R Goulder; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.

Authors:  Carlum Shiu; Coleen K Cunningham; Thomas Greenough; Petronella Muresan; Victor Sanchez-Merino; Vincent Carey; J Brooks Jackson; Carrie Ziemniak; Lawrence Fox; Marvin Belzer; Stuart C Ray; Katherine Luzuriaga; Deborah Persaud
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

7.  Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.

Authors:  Christian B Willberg; Keith E Garrison; R Brad Jones; Duncan A Meiklejohn; Gerald Spotts; Teri J Liegler; Mario A Ostrowski; Annika C Karlsson; Frederick M Hecht; Douglas F Nixon
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

8.  Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker.

Authors:  Tim Beaumont; Esther Quakkelaar; Ad van Nuenen; Ralph Pantophlet; Hanneke Schuitemaker
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Human immunodeficiency virus-specific CD8(+) T cells in human breast milk.

Authors:  Steffanie Sabbaj; Bradley H Edwards; Mrinal K Ghosh; Katherine Semrau; Sanford Cheelo; Donald M Thea; Louise Kuhn; G Douglas Ritter; Mark J Mulligan; Paul A Goepfert; Grace M Aldrovandi
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.

Authors:  Mark A Brockman; Arne Schneidewind; Matthew Lahaie; Aaron Schmidt; Toshiyuki Miura; Ivna Desouza; Faina Ryvkin; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Joseph Mulenga; Paul A Goepfert; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.